Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?

about

Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.

P2860

Q52617485-7FE93C5F-EBD7-4017-8CE3-D0E8BE0F0BB2

P2860

Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?

Item

http://www.wikidata.org/entity/Q38971554

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Human Papillomavirus (HPV): A ...... arcinoma of the Head and Neck?

@en

type

Item

label

Human Papillomavirus (HPV): A ...... arcinoma of the Head and Neck?

@en

prefLabel

Human Papillomavirus (HPV): A ...... arcinoma of the Head and Neck?

@en

P1433

P1476

Human Papillomavirus (HPV): A ...... arcinoma of the Head and Neck?

@en

P2093

Jan B Vermorken

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck

Human papillomavirus and survival of patients with oropharyngeal cancer.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.

Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Case-control study of human papillomavirus and oropharyngeal cancer

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

P304

137-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-43580-0_10

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27699535

http://www.w3.org/2001/XMLSchema#string